Using infrared light to improve memory in people with mild cognitive impairment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of photobiomodulation (PBM) therapy on individuals with mild cognitive impairment (MCI) due to Alzheimer's disease. Approximately 60 participants will be recruited to undergo treatment with either an active or sham Neuro RX gamma device over a 12-week period. The device includes a headset and nasal applicator that deliver low-level light therapy aimed at enhancing cognitive function. The study aims to provide a non-invasive alternative to current pharmacological treatments for MCI.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Individuals who meet the criteria for MCI of 1) cognitive concern by the subject, informant, or clinician; 2) Montreal Cognitive Assessment (MoCA) score between 19-25 and impairment in learning and memory domain; 3) essentially normal functional activities as derived from the Clinical Dementia Rating Scale (CDR) and 4) the National Institute on Aging and Alzheimer's Association (NIA-AA) criteria for MCI due to Alzheimer's disease. , Age is greater than or equal to 50 years old. Meets the National Institute on Aging and Alzheimer's Association (NIA-AA) criteria for MCI due to Alzheimer's disease.

Essentially normal functional activities as derived from the CDR. If receiving ongoing cholinesterase inhibitor therapy and/or memantine, must be on a stable dosage for at least the prior 3 months.

MoCA score between 19 and 25 at screening assessment and impairment in learning and memory domain.

Exclusion Criteria:

Cannot tolerate blood draws. Claustrophobia (fear of small or enclosed spaces), that cannot tolerate MRI scanners\*.

A pace-maker or other metal implants that would preclude safe use of MRI\*. DSM 5 diagnosis of alcohol or other substance use disorders within the past 12 months.

Unstable medical illness, (e.g., uncontrolled diabetes mellitus or hypertension).

Any history of stroke, seizures, MS, or Lyme disease. Any issues with ambulation, vision, or hearing which could, in the opinion of the investigator, interfere with their ability to complete assessments.

Participant does not speak English at a level necessary for the completion of the assessments.

Has not completed at least a grade eight education, as necessary for the completion of the assessments.

Currently participating in another clinical research study involving an investigational product.

History of significant agitation and/or aggression, epileptic seizures. Current neurologic disease affecting cognition other than Alzheimer's disease. Photosensitivity reactions to sunlight or visible light (polymorphous light eruption, solar urticaria, persistent light reactivity).

History of recurrent epistaxis within the last 24 weeks or currently taking major anti-coagulants (including warfarin, low molecular weight heparin) Increased skin sensitivity at the treatment site including active herpes simplex in the treatment area, history of keloid formation, or history of retinoid use in the past month.

Pregnant or lactating or planning to become pregnant. Currently undergoing infrared light therapy treatment. Any reason that, in the opinion of the investigator, might place a participant at unacceptable risk for participation in the trial.

Note: \*Participants with contraindications for MRI can still enroll in the trial and participate without undergoing the MRI procedure. However, if participants do not have contraindications, undergoing the MRI is required as part of the trial.

Where it's running

• St. Michael's Hospital, Unity Health Toronto
  Toronto, Ontario, Canada Recruiting

Study contacts

• Study coordinator: Corinne Fischer, MD, FRCP(C)
• Email: Corinne.Fischer@unityhealth.to
• Phone: 416-360-4000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• LIFU to Help Sleep and Amyloid Reduction in Older Adults with Cognitive Impairment

  A wearable ultrasound device (ATTN201) is being tested to see if it’s safe and easy to use for people 65 and older with mild cognitive impairment and amyloid buildup.

  Recruiting University of California, San Francisco · San Francisco, California · NCT07866768

• Longitudinal profiling of plasma-derived glial extracellular vesicles in Alzheimer's disease

  This study tests whether plasma glial extracellular vesicles and neuroinflammation biomarkers change over time across the Alzheimer’s disease spectrum and whether these signals relate to amyloid, tau, and neurodegeneration, with an additional step of exposing healthy iPSC-derived neurons to vesicles to see potential ne

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Rome · NCT07803055

• Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns

  This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.

  Recruiting University of Cambridge · Cambridge, CB2 · NCT07786116

• Non-invasive brain stimulation to try to improve memory in early Alzheimer's

  Scientists test whether repetitive transcranial magnetic stimulation to the cerebellum can help short-term memory in people with early Alzheimer's disease compared with a sham procedure.

  Recruiting Baylor College of Medicine · Houston, Texas · NCT07667478

• Leronlimab for brain inflammation in Alzheimer's disease

  This study will test whether weekly injections of leronlimab are safe and can reduce brain inflammation in people over 50 with Alzheimer's disease or mild cognitive impairment due to Alzheimer's.

  Recruiting Phase 2 Weill Medical College of Cornell University · New York, New York · NCT07553338

• Mindfulness meditation for improving cognition in older adults

  This study is testing whether mindfulness meditation can help older adults, including those with mild cognitive impairment, improve their thinking, memory, and overall quality of life.

  Recruiting VA Boston Healthcare System · Boston, Massachusetts · NCT06792877

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.